The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
Open Access
- 8 November 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 32 (3), 779-792
- https://doi.org/10.1007/s11095-013-1231-0
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid TumorsClinical Cancer Research, 2010
- Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysisCancer Immunology, Immunotherapy, 2009
- A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and LymphomasClinical Cancer Research, 2008
- NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificitiesBlood, 2008
- Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cellsLeukemia, 2007
- ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15Blood, 2006
- The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D–target-cell interactionsBlood, 2005
- Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium ValproateCancer Research, 2005
- An economical adaptation of the RosetteSep™ procedure for NK cell enrichment from whole blood, and its use with liquid nitrogen stored peripheral blood mononuclear cellsJournal of Immunological Methods, 2003
- An Activating Immunoreceptor Complex Formed by NKG2D and DAP10Science, 1999